Interactive Hand Exercise Game on Grip Strength and Vascular Maturation
Launched by TAIPEI MEDICAL UNIVERSITY · Aug 8, 2022
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a fun and interactive hand exercise game designed to improve grip strength and help the blood vessels mature in patients undergoing hemodialysis. Hemodialysis is a treatment for people with severe kidney problems, and it often requires a special surgical connection called an arteriovenous fistula. By using smart technology and engaging exercises, the goal is to make patients more motivated to participate in their rehabilitation and improve their overall health.
To participate in this trial, individuals need to be between 20 and 70 years old and have a diagnosis of chronic kidney failure, either before starting dialysis or after beginning hemodialysis with a newly created arteriovenous fistula. Participants should be able to communicate in Chinese and have clear awareness of their surroundings. However, those with certain conditions, like previous problems with their fistula or specific arm injuries, won’t be eligible. If you join this study, you can expect to engage in enjoyable exercises that could help strengthen your hand and potentially improve your treatment experience.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of chronic renal failure stage 4 to 5 (before dialysis) and stage 5 (patients who have started hemodialysis).
- • Newly established surgical patients with autologous arteriovenous fistula.
- • Aged between 20 and 70 years old.
- • Having clear consciousness and being able to communicate in Chinese.
- Exclusion Criteria:
- • Previous dysfunction of an autologous arteriovenous fistula in the same arm.
- • Injury to the fistula extremity.
- • Neuromusculoskeletal abnormalities.
- • Upper extremity arthritis.
- • Peripheral neuropathy.
- • Peripheral arterial dysfunction.
- • Venous disease.
- • Rheumatic disease.
About Taipei Medical University
Taipei Medical University (TMU) is a leading educational and research institution located in Taipei, Taiwan, dedicated to advancing health sciences and clinical research. Established with a focus on fostering innovation in medical education, TMU integrates comprehensive clinical training with rigorous research methodologies. The university is committed to improving patient outcomes through a strong emphasis on translational medicine and interdisciplinary collaboration. TMU's clinical trial initiatives are designed to explore new treatments and therapies, contributing to the global body of medical knowledge while adhering to the highest ethical standards and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Chiu Hsiao-Yean, PhD
Principal Investigator
Taipei Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials